Antioxidant studies need a change of direction

Mehdi H. Shishehbor, DO
Department of Internal Medicine, Department of Cell Biology, and the Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Stanley L. Hazen, MD, PhD
Section Head, Department of Preventive Cardiology and Cardiac Rehabilitation; Department of Cell Biology, Department of Cardiovascular Medicine; Director, Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Address: Stanley L. Hazen, MD, PhD, Section of Preventive Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Hazen has indicated that he is on the speakers’ bureau of Merck & Co., Inc., and is a consultant for Prognostix, a company specializing in technology to diagnose cardiovascular disease and asthma.

Mehdi H. Shishehbor, DO
Department of Internal Medicine, Department of Cell Biology, and the Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Stanley L. Hazen, MD, PhD
Section Head, Department of Preventive Cardiology and Cardiac Rehabilitation; Department of Cell Biology, Department of Cardiovascular Medicine; Director, Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Address: Stanley L. Hazen, MD, PhD, Section of Preventive Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Hazen has indicated that he is on the speakers’ bureau of Merck & Co., Inc., and is a consultant for Prognostix, a company specializing in technology to diagnose cardiovascular disease and asthma.

Mehdi H. Shishehbor, DO
Department of Internal Medicine, Department of Cell Biology, and the Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Stanley L. Hazen, MD, PhD
Section Head, Department of Preventive Cardiology and Cardiac Rehabilitation; Department of Cell Biology, Department of Cardiovascular Medicine; Director, Center for Cardiovascular Diagnostics and Prevention, The Cleveland Clinic Foundation

Address: Stanley L. Hazen, MD, PhD, Section of Preventive Cardiology, C51, The Cleveland Clinic Foundation, 9500 Euclid Avenue, Cleveland, OH 44195; e-mail [email protected]

Dr. Hazen has indicated that he is on the speakers’ bureau of Merck & Co., Inc., and is a consultant for Prognostix, a company specializing in technology to diagnose cardiovascular disease and asthma.